Preview Newsletter

Midday Talc Report

Traditional US Coverage

St. Louis jury rejects lawsuit against Johnson & Johnson (UPDATE)
Mar 3, 2017 | Associated Press

A St. Louis jury on Friday rejected a Tennessee woman's lawsuit that Johnson & Johnson baby powder contributed to her ovarian cancer, a victory for the company after it lost three previous, similar lawsuits in St. Louis.
J&J wins trial in talc product liability lawsuits (UPDATE)
Mar 3, 2017 | Reuters
By Nate Raymond

Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the latest trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.
St. Louis jury rejects woman's claims talcum powder contributed to her cancer
Mar 3, 2017 | St. Louis Post-Dispatch
By Joel Currier

A jury here Friday rejected a woman's claims that her longtime use of baby powder made by Johnson & Johnson contributed to her ovarian cancer.
J&J Gets Its First Win In Mo. Talcum Powder Trials
Mar 3, 2017 | Law360
By Cara Salvatore

A Missouri jury on Friday returned a complete defense verdict for Johnson & Johnson and Imerys Talc America in a case attempting to link a woman’s ovarian cancer to talcum powder, breaking a string of massive victories for plaintiffs in the closely watched litigation.
Johnson & Johnson Wins Fourth Lawsuit Tied to Talcum Powder
Mar 3, 2017 | TheStreet
By Tony Owusu

A Missouri court ruled in favor of Johnson & Johnson (JNJ) in a civil case involving a woman who had used the company's talcum powder for 36 years before she developed ovarian cancer in 2013.
J&J Wins Jury Trial, Ends String of Losses in Talc Cases
Mar 3, 2017 | The National Law Journal
By Amanda Bronstad

Rebounding from a trio of courtroom defeats, Johnson & Johnson scored a defense win on Friday as a jury in Missouri found its baby powder did not cause a Tennessee woman’s ovarian cancer.
BREAKING: Johnson & Johnson Cleared in Talcum Powder-Cancer Trial
Mar 3, 2017 | CNV
By Arlin Crisco

Jurors cleared Johnson & Johnson and its talc supplier Friday afternoon of responsibility for the ovarian cancer a woman claims was caused by years of using the consumer giant’s baby powder products. Swann v. Johnson & Johnson, 1422-CC09326-01.

US Broadcast

6 News This Morning
Mar 4, 2017 | WLNS CBS (Lansing, MI)

View clip here: http://app.criticalmention.com/app/#clip/view/26339376?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Fox 4 News at 10:30
Mar 3, 2017 | WDAF Fox (Kansas City, MO)

View clip here: http://app.criticalmention.com/app/#clip/view/26339377?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
WENY News at 11
Mar 3, 2017 | WENYDT2 CBS (Elmira, NY)

View clip here: http://app.criticalmention.com/app/#clip/view/26339379?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
News 4 at 10pm
Mar 3, 2017 | KMOV CBS (St. Louis, MO)

View clip here: http://app.criticalmention.com/app/#clip/view/26339380?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Local 6 at 10:00
Mar 3, 2017 | WPSD NBC (Paducah, KY)

View clip here: http://app.criticalmention.com/app/#clip/view/26339381?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Fox 8 News at 9pm
Mar 3, 2017 | WVUE-FOX (New Orleans, LA)

View Clip Here:http://app.criticalmention.com/app/#clip/view/26339382?token=c30918cc-0aa6-4667-96f3-41ab2da450bb
Fox 2 News at 6:00pm
Mar 3, 2017 | KTVI-FOX (St. Louis, MO)

View Clip Here: http://app.criticalmention.com/app/#clip/view/26333541?token=0a55f15a-b651-4f94-b99d-2e797192f8c0
NPR Radio Segment
Mar 4, 2017 | NPR

Listen to Clip Here: http://app.criticalmention.com/app/#clip/view/26339383?token=c30918cc-0aa6-4667-96f3-41ab2da450bb

Full Text of Stories Below

Traditional US Coverage

St. Louis jury rejects lawsuit against Johnson & Johnson (UPDATE)

Mar 3, 2017 | Associated Press

A St. Louis jury on Friday rejected a Tennessee woman's lawsuit that Johnson & Johnson baby powder contributed to her ovarian cancer, a victory for the company after it lost three previous, similar lawsuits in St. Louis.
The jury voted 11-1 to deny damages to Nora Daniels, 55, of Columbia, Tenn., who said she used Johnson & Johnson's talcum powder from 1978 to 2013, when she was diagnosed with ovarian and uterine cancer. She also sued Imerys Talc, a talcum powder supplier, the St. Louis Post-Dispatch reported.
The verdict for Johnson & Johnson came after three previous St. Louis juries awarded a total of $197 million to plaintiffs who made similar claims. About 2,000 state and federal lawsuits are in courts across the country over concerns about health problems caused by prolonged talcum powder use.
Daniels' lawyer, Jim Onder, said he thinks the difference between Friday's verdict and the three previous St. Louis cases was that this jury didn't think the talcum powder contributed to Daniels' specific type of cancer.
Johnson & Johnson spokeswoman Carol Goodrich said in a statement the company sympathizes with ovarian cancer patients.
"The jury's decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc," the statement said while citing two cases thrown out in New Jersey in September 2016, when a judge found insufficient scientific evidence for the claims against talcum powder.
Imerys spokeswoman Gwen Myers said in a statement the jury followed "the science that establishes the safety of talc."
"Imerys sympathizes with women suffering from ovarian cancer and hopes that the scientific community's efforts will continue to be directed toward finding the true causes of this terrible disease," the statement said.
Juror Luke Wilson, 34, of St. Louis said the jury did not think evidence linking talcum powder with ovarian cancer was strong enough to require Johnson & Johnson to put warning labels on its products.
The only dissenting juror, George Stair, 76, of St. Louis, said he thought there was enough evidence.
"I wish we could have sent a message to Johnson & Johnson to put a warning on the product label," he said.

Return to headline | Return to top
J&J wins trial in talc product liability lawsuits (UPDATE)

Mar 3, 2017 | Reuters

By Nate Raymond

Johnson & Johnson said on Friday that a state court jury in Missouri had returned a verdict in its favor in the latest trial to arise out of thousands of lawsuits alleging the company's talc-based products can increase the risk of ovarian cancer.
The jury sided with Johnson & Johnson and talc supplier Imerys Talc in a lawsuit by Tennessee resident Nora Daniels, who alleged that she used J&J Baby Powder for 36 years and was diagnosed with ovarian cancer in 2013.
The verdict came after three straight prior jury verdicts in St. Louis against J&J awarding plaintiffs a combined $195 million. More than 2,500 lawsuits are pending in state court in St. Louis.
"The jury's decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc," Johnson & Johnson said in a statement.
Imerys in a statement thanked the jury "for following the science that establishes the safety of talc."
Ted Meadows, a lawyer for Daniels, in a statement said he was disappointed by the verdict.
"We continue to maintain that the association between genital talc usage and ovarian cancer remains an issue of public health and demands that consumers be warned of the specific risks," he said in a statement.
Plaintiffs have accused J&J of failing for years to warn that talc was linked to an increased risk for ovarian cancer. J&J has said it acted properly in developing and marketing the products.
In February 2016, a Missouri state jury ordered J&J to pay $72 million to the family of a woman who died from ovarian cancer after years of using talc powder for feminine hygiene.
In May, another jury in Missouri returned $55 million to a woman who said the company's talc-powder products caused her to develop ovarian cancer. J&J was subsequently hit with a third verdict in October for $67.5 million.

Return to headline | Return to top
St. Louis jury rejects woman's claims talcum powder contributed to her cancer

Mar 3, 2017 | St. Louis Post-Dispatch

By Joel Currier

A jury here Friday rejected a woman's claims that her longtime use of baby powder made by Johnson & Johnson contributed to her ovarian cancer.
The 11-1 verdict for Johnson & Johnson follows three earlier St. Louis jury verdicts totaling $197 million against the company last year and are among about 2,000 pending state and federal lawsuits.
Nora Daniels, 55, of Columbia, Tenn., sued Johnson and Johnson and Imerys Talc America, J&J's talcum powder supplier. Daniels, a mother of two, used Johnson & Johnson's talcum powder from 1978 to 2013 when she was diagnosed with ovarian and uterine cancer.
Daniels' lawyer, Jim Onder, said Friday's verdict, while disappointing, "helps define what cases should and shouldn't be compensated." Onder said he thinks the jury did not see an association between talcum powder and Daniels' specific type of ovarian cancer.
"You've got to respect the process," he said. He said the next talcum powder trials are scheduled for April and June.
In a statement Friday, a Johnson & Johnson spokeswoman said the company sympathizes with ovarian cancer patients. "The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc." J &J's statement noted two cases thrown out of New Jersey state court last fall after the judge found inadquate scientific evidence for teh suit's claims.
Imerys also praised the jury's verdict "for following the science that establishes the safety of talc," according to a statement attributed to an Imerys spokeswoman. "Imerys sympathizes with women suffering from ovarian cancer and hopes that the scientific community’s efforts will continue to be directed toward finding the true causes of this terrible disease."
St. Louis juries in the earlier cases found that Johnson & Johnson failed to warn the public of studies linking its talc-containing products like Shower-to-Shower product and Johnson’s Baby Powder to ovarian cancer.
All four cases were handled by the Onder Law Firm of Webster Groves, which has advertised nationwide for ovarian cancer patients who suspect baby powder may be linked to their disease.
As a result of the verdicts, a pro-business lobbying group in December labeled the city's circuit court as the nation’s “most unfair” jurisdiction for civil lawsuits. Republican Gov. Eric Greitens has pledged to alter the state’s legal landscape as part of a pro-business push favored by the GOP-controlled House and Senate.
In October, a St. Louis jury awarded $70 million to a California woman who used talcum powder regularly for years and diagnosed with ovarian cancer in 2012. In May, a jury here ordered the company to pay $55 million to a survivor in South Dakota. In February 2016, a jury awarded $72 million to relatives of an Alabama woman who died of ovarian cancer.
The verdict in October was the first to find Imerys Talc at fault.
Talcum powder products contain the mineral talc that can absorb moisture and prevent chafing and rash. It is used in eye shadow, blush and some chewing gums as well as baby powder. Some talc naturally contains asbestos, which is known to cause lung cancer. Asbestos has been removed from household talcum products since the 1970s.
The American Cancer Society states research into talc and ovarian cancer is ongoing, and “until more information is available, people concerned about using talcum powder may want to avoid or limit their use of consumer products that contain it.”

Return to headline | Return to top
J&J Gets Its First Win In Mo. Talcum Powder Trials

Mar 3, 2017 | Law360

By Cara Salvatore

A Missouri jury on Friday returned a complete defense verdict for Johnson & Johnson and Imerys Talc America in a case attempting to link a woman’s ovarian cancer to talcum powder, breaking a string of massive victories for plaintiffs in the closely watched litigation.
Nora Daniels, who said Johnson & Johnson’s talcum powder caused her 2013 ovarian cancer, was unable to convince the jury that her disease was connected to 38 years’ worth of daily talcum powder use.
In the fourth case to go to trial in the litigation, the jurors found in favor of J&J on a misrepresentation by concealment count, in favor of Johnson & Johnson Consumer Cos. Inc. on negligence and product liability failure to warn claims, and in favor of supplier Imerys Talc America on negligence and misrepresentation by concealment claims.
A poll after the verdict reading revealed that 11 of the 12 jurors agreed on the verdict; only nine were needed for a valid verdict. The jury deliberated for less than a day.
The trial kicked off Feb. 9 as one of Daniels’ attorneys, Ted Meadows of Beasley Allen, said the company’s “love of money result[ed] in all manner of evil” for women who used its baby powder.
Meadows said Friday that his team was disappointed about the verdict but vowed to fight on.
“We continue to maintain that the association between genital talc usage and ovarian cancer remains an issue of public health and demands that consumers be warned of the specific risks,” he said in a statement Friday.
Meadows also noted that Daniels was selected by the defense as a plaintiff.
In a statement Friday, J&J Consumer spokeswoman Carol Goodrich said, "We deeply sympathize with the women and families impacted by ovarian cancer. The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world."
The first St. Louis talc trial centered on the ovarian cancer death of Jacqueline Fox. In February 2016, jurors awarded Fox's estate $72 million. In the second trial, plaintiff Gloria Ristesund was awarded $55 million in May. Plaintiff Deborah Giannecchini was awarded $70 million in October.
Further St. Louis talc trials are set for April, June and July, and a first California trial is set for July.
Daniels is represented by Ted Meadows, David Dearing and Danielle Mason of Beasley Allen, and Allen Smith of Talc Litigation Group and The Smith Law Firm PLLC.
Johnson & Johnson is represented by Bart Williams and Manuel Cachán of Proskauer Rose LLP, Kimberly Dunne of Sidley Austin LLP and Thomas Magee of HeplerBroom.
The case is Swann v. Johnson & Johnson, case number 1422-CC09326-01, in the 22nd Judicial Circuit Court of Missouri.
For more coverage of this trial, visit Courtroom View Network

Return to headline | Return to top
Johnson & Johnson Wins Fourth Lawsuit Tied to Talcum Powder

Mar 3, 2017 | TheStreet

By Tony Owusu

A Missouri court ruled in favor of Johnson & Johnson (JNJ) in a civil case involving a woman who had used the company's talcum powder for 36 years before she developed ovarian cancer in 2013.

Johnson & Johnson had lost three previous cases involving the discontinued product, awarding plaintiffs $195 million.

Return to headline | Return to top
J&J Wins Jury Trial, Ends String of Losses in Talc Cases

Mar 3, 2017 | The National Law Journal

By Amanda Bronstad

Rebounding from a trio of courtroom defeats, Johnson & Johnson scored a defense win on Friday as a jury in Missouri found its baby powder did not cause a Tennessee woman’s ovarian cancer.
The verdict, coming a month after trial began, is the first defense win among talcum powder trials involving Johnson & Johnson. The company lost verdicts of $55 million, $70 million and $72 million last year in Missouri.
“The jury’s decision is consistent with the science, research, clinical evidence and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc,” said J&J spokeswoman Carol Goodrich. New Jersey-based Johnson & Johnson, previously represented by Shook Hardy & Bacon, also brought in a new defense team led by Bart Williams and Manuel Cachán of Proskauer Rose to handle the trial.
Lead plaintiffs attorney Ted Meadows, principal at Beasley, Allen, Crow, Methvin, Portis & Miles in Montgomery, Alabama, said he was disappointed. He noted that the case had been selected by the defendants for trial.
“As always, we will learn from the experience of this trial, and we are committed to carrying the fight forward with the legal claims of thousands of innocent victims whose lives have been shattered by ovarian cancer,” he said. “We look forward to the upcoming trial in April, which has its own distinctive set of claims and circumstances.”
The jury also returned a defense verdict for Imerys Talc North America. Imerys spokeswoman Gwen Myers said in a statement: “Imerys utilizes a rigorous set of proprietary safety procedures in the production of talc, and we are confident that our talc is safe. This jury's finding validates that fact and reflects the consensus of government agencies and professional scientific organizations that talc is safe.”
The trial involved Nora Daniels, 56, a resident of Columbia, Tennessee, who alleges her use of Johnson & Johnson’s baby powder for 36 years caused her to be diagnosed with ovarian cancer in 2013. Her cancer is now in remission following a hysterectomy and five months of chemotherapy.
Johnson & Johnson joins a chorus of tort reformers nationwide that have blamed Missouri’s rules on expert testimony for a string of losses last year in the 22nd Circuit Court in St. Louis, where most of the 1,700 women with ovarian cancer have sued the pharmaceutical firm. Johnson & Johnson also tried to get the case in Friday’s verdict removed to federal court just prior to trial.

Return to headline | Return to top
BREAKING: Johnson & Johnson Cleared in Talcum Powder-Cancer Trial

Mar 3, 2017 | CNV

By Arlin Crisco

Jurors cleared Johnson & Johnson and its talc supplier Friday afternoon of responsibility for the ovarian cancer a woman claims was caused by years of using the consumer giant’s baby powder products. Swann v. Johnson & Johnson, 1422-CC09326-01.
The jury, in Missouri's 22nd Judicial Circuit, deliberated about seven hours before finding against Nora Daniels in her claims against J&J and Imerys Talc America.
Eleven of the 12 jurors signed the verdict, which needed the agreement of at least nine members.
Daniels, 55, was diagnosed with ovarian cancer in 2013, and underwent a hysterectomy, as well as the removal of her ovaries and fallopian tubes, as part of her treatment. She claims her cancer was caused by the use of J&J’s baby powder products, and the company’s refusal to warn of the alleged link between its talc and ovarian cancer.
Daniels’ case is one of thousands of similar lawsuits, largely concentrated in Missouri, California, and New Jersey, against J&J. While Imerys has been cleared of liability in two previous Missouri cases, this is J&J's first talc trial win in Missouri state court, which handed down three plaintiff’s verdicts topping $190 million combined last year.
The three-week trial focused on the science surrounding the link between talc and ovarian cancer, as well as Johnson & Johnson’s response to these studies. During his closing argument Thursday, Daniels’ attorney, Allen Smith, of the Smith Law Firm, said J&J was aware of more than 30 epidemiological studies tying talc use to an increased ovarian cancer risk over the last three decades. “Thirty-five years of study, nearly every one of them shows an increased risk,” Smith said. “Nearly every single one of them.”
Despite these studies, and talc’s "possibly carcinogenic" classification more than a decade ago by the International Agency for Research on Cancer, or IARC, Smith said J&J steadfastly refused to include a warning on its baby powder products. “The important thing is [Daniels] would not have used the product and we might not have even been here, had they just placed a warning on the product,” Smith said.
Instead, Smith told jurors the company employed tactics similar to tobacco industry schemes to conceal the dangers of smoking, and he said J&J used its power to stymie regulations against talc and quiet rumblings of the powder’s alleged health hazards. “Unless you make them warn, unless you make them change their behavior, they’re not going to do it. It’s shown over the past 35 years,” Smith said. “They will influence organizations, they’ll use their political influence [in] the highest office in the land to roll back regulations."
Smith did not request a specific amount in compensatory or punitive damages Thursday, but told jurors the award "has got to be something that makes them change their conduct."
However, the defense argued any link between talc and cancer shown by epidemiological studies was weak and ultimately disproven by stronger, prospective studies. During Thursday’s closings, Proskauer’s Bart Williams walked jurors through the science he said established that talc could not have caused Daniels’ cancer. “Each and every one of the prospective studies, each and every one of them, of the ones that look forward and follow women along, has found that there is no connection between the use of talc and ovarian cancer,” Williams said.
Williams reminded jurors that agencies ranging from the National Cancer Institute to the Centers for Disease Control and Prevention had reviewed the scientific data and found no cause-and-effect link between talc and cancer. While he acknowledged the IARC classified talc as “possibly” carcinogenic, he noted talc shared that so-called 2B classification with items as commonplace as pickled vegetables and, until last year, coffee. “Have you ever in your life seen, for any coffee you’ve ever purchased from anywhere, a warning that says that coffee may cause cancer? No, of course you haven’t,” Williams said. “It is ridiculous that something listed on IARC as 2B would trigger an obligation to warn.”
Imerys lawyers argued the company met any duty to warn, despite the fact that it believes talc does not cause cancer. During her closing Thursday, Gordon & Rees’ Nancy Erfle reminded jurors Imerys, which only supplies talc to companies like J&J, has long published the mineral’s IARC classification on the Material Safety Data Sheet, or MSDS, it provides its clients. “Our MSDS tells the companies that buy our talc the safety information they need to know,” Erfle said. “It’s not possible for Imerys to put a warning on a final product that the talc is used in. We can’t put warnings on bottles of Johnson & Johnson Baby Powder or Shower to Shower.”
After the verdict, J&J said the jury’s decision upheld the stronger scientific evidence. “We deeply sympathize with the women and families impacted by ovarian cancer,” J&J spokesperson Carol Goodrich said in an emailed statement on behalf of the company. “The jury’s decision is consistent with the science, research, clinical evidence, and decades of studies by medical experts around the world that continue to support the safety of cosmetic talc,” Goodrich added, noting a New Jersey court dismissed two cases last year after rejecting scientific studies proffered by plaintiffs.

Beasley Allen’s Ted Meadows, who represents Davis and other talc plaintiffs, noted his firm is disappointed with the verdict but looking ahead to the next trial, which is expected to begin in April. “We continue to maintain that the association between genital talc usage and ovarian cancer remains an issue of public health and demands that consumers be warned of the specific risks,” Meadows wrote in an emailed statement. “[Nora Daniels] was among multiple possible plaintiffs selected by the defense for this trial. As always, we will learn from the experience of this trial, and we are committed to carrying the fight forward with the legal claims of thousands of innocent victims whose lives have been shattered by ovarian cancer.”

Return to headline | Return to top

US Broadcast

6 News This Morning

Mar 4, 2017 | WLNS CBS (Lansing, MI)

View clip here: http://app.criticalmention.com/app/#clip/view/26339376?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Rough transcript: in saint louis the court has rejected a woman's claim that johnson and johnson baby powder gave her ovarian cancer. it's also noticed help them powder the company has paid out nearly two hundred million dollars and settlements on similar cases. customers have filed nearly two thousand state and federal lawsuits linking johnson and johnson talcum powder to ovarian cancer.

Return to headline | Return to top
Fox 4 News at 10:30

Mar 3, 2017 | WDAF Fox (Kansas City, MO)

View clip here: http://app.criticalmention.com/app/#clip/view/26339377?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Rough transcript: a st louis jury has rejected a woman's claim that johnson and johnson baby powder contributed to her ovarian cancer. a woman from columbia, tennesee said she used the company's talcum powder from 1978 to 2013 when she was diagnosed with ovarian and uterine cancer. the verdict was eleven- to- one last year. three st. louis juries awarded three woman a total of 197- milion dollars in damages for claims baby powder caused their cancers.

Return to headline | Return to top
WENY News at 11

Mar 3, 2017 | WENYDT2 CBS (Elmira, NY)

View clip here: http://app.criticalmention.com/app/#clip/view/26339379?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Rough transcript: a jury has rejected a woman's claim that johnson & johnson baby powder contributed to her ovarian cancer. the 11 to 1 verdict came earlier today in a lawsuit filed by 55-year-old tennessee woman. the verdict for johnson & johnson reportedly came after three previous juries ruled against the company in similar lawsuits. those verdicts last year awarded a total of 197 million to the plantiffs.. about 2,000 state and federal lawsuits have been filed against the company claiming a link between the powder and ovarian cancer.

Return to headline | Return to top
News 4 at 10pm

Mar 3, 2017 | KMOV CBS (St. Louis, MO)

View clip here: http://app.criticalmention.com/app/#clip/view/26339380?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Rough transcript: new tonight a jury has rejected a woman's lawsuit against johnson & johnson. she claims that company's baby powder contributed to her ovarian cancer. the decision comes after johnson & johnson lost three previous lawsuits with similar arguments. about 2000 state and federal lawsuits have been filed claiming a link between baby powder and ovarian cancer.

Return to headline | Return to top
Local 6 at 10:00

Mar 3, 2017 | WPSD NBC (Paducah, KY)

View clip here: http://app.criticalmention.com/app/#clip/view/26339381?token=9e2e2ba5-f7f8-4f5e-b6e0-cf666d2e6e1a
Rough transcript: johnson and johsnon baby powder did not contribute to ovarian cancer. that's the verdict today by a jury in st. louis, missouri in a case brought on by a woman in tennessee. the woman claimed she was diagnosed with ovarian and uterine cancer while using the company's talcum powder. the st. louis post-dispatch reports today's verdict comes after three previous st. louis juries found against the company in similar lawsuits.

Return to headline | Return to top
Fox 8 News at 9pm

Mar 3, 2017 | WVUE-FOX (New Orleans, LA)

View Clip Here:http://app.criticalmention.com/app/#clip/view/26339382?token=c30918cc-0aa6-4667-96f3-41ab2da450bb
Rough Transcript: a saint louis jury has rejected a woman's claim that johnson & johnson baby powder contributed to her ovarian cancer. today's 11-1 verdict came in a lawsuit filed by a tennessee woman against johnson & johnson and imerys talc, a talcum powder supplier. the st. louis post-dispatch reports the verdict for johnson & johnson came after three previous st. louis juries found against the company in similar lawsuits. those verdicts last year awarded a total of 197 million the company in similar lawsuits. those verdicts last year awarded a total of 197 million dollars to the plaintiffs. thousands

Return to headline | Return to top
Fox 2 News at 6:00pm

Mar 3, 2017 | KTVI-FOX (St. Louis, MO)

View Clip Here: http://app.criticalmention.com/app/#clip/view/26333541?token=0a55f15a-b651-4f94-b99d-2e797192f8c0

Return to headline | Return to top
NPR Radio Segment

Mar 4, 2017 | NPR

Listen to Clip Here: http://app.criticalmention.com/app/#clip/view/26339383?token=c30918cc-0aa6-4667-96f3-41ab2da450bb
Rough Transcript: a saint louis jury has rejected a woman's claim that johnson and johnson baby powder contributed to her ovarian cancer. friday's eleven to one verdict came in a lawsuit filed by %hesitation tennessee woman against johnson and johnson and the talcum pouder supplier. three previous verdicts last year awarded a total of one hundred ninety seven million dollars and thousands of suits are pending

Return to headline | Return to top

Full Text of Stories Below

Add recipients

Suggested